- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04328857
Experimentation of Sensorized Pseudoelastic Orthoses Produced by Additive Manufacturing
The proposed clinical investigation plan is a pivotal controlled study with two parallel groups, has a total duration of 12 months and involves the recruitment of 34 pediatric patients suffering from acquired brain injury.
The primary objective of the clinical study is to evaluate the improvement of joint stiffness through the use of sensorized pseudoelastic orthoses for the rehabilitation of pediatric patients with acquired brain injury.
The effectiveness of the treatment in terms of joint stiffness (primary outcome) will be assessed and the effect of the treatment will be quantified with clinical evaluation scales and instrumental measurements by means of an optoelectronic system and isokinetic machine. The tolerability and acceptability of the device will also be checked.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elena Beretta
- Phone Number: 031877851
- Email: elena.beretta@lanostrafamiglia.it
Study Contact Backup
- Name: FAbio A Storm
- Email: fabio.storm@lanostrafamiglia.it
Study Locations
-
-
LC
-
Bosisio Parini, LC, Italy, 23842
- Recruiting
- IRCCS Eugenio Medea
-
Contact:
- Elena Beretta, MD
- Phone Number: +39031877111
- Email: elena.beretta@lanostrafamiglia.it
-
Sub-Investigator:
- Fabio A Storm
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Quadriplegia or acquired hemiplegia.
- Age 6-20 years.
- Dystonic, dyskinetic, spastic.
- Chronic phase patients (> 1 year post event).
- Spastic syndrome with Ashworth Score (AS) for the limb of interest> 1.
- Collaborative.
Exclusion Criteria:
- Fixed limitations of the joint.
- Joint pain.
- Skin allergies.
- Behavioral and psychiatric disorders (eg, emotional problems, anxiety, panic attacks).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Treatment
Upper limb rehabilitation with pseudoelastic orthosis
|
The subject will be given specific physiotherapy including activities oriented to multimodal exploration and refinement of gross and fine motor skills, customized according to the functional status of the individual patient.
|
|
NO_INTERVENTION: Control
Upper limb rehabilitation without pseudoelastic orthosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Joint Stiffness of affected upper limb joint
Time Frame: After 4 weeks of treatment
|
Quantitative measure performed by means of an isokinetic machine (Unit of measure: Nm/°).
Changes in joint stiffness following the use of new customized devices during a rehabilitation treatment period.
Lower stiffness is better.
|
After 4 weeks of treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Ashworth Scale
Time Frame: After 4 weeks of treatment
|
Clinical scale for spasticity (5 levels), higher is worse.
|
After 4 weeks of treatment
|
|
Melbourne Upper Limb Assessment 2
Time Frame: After 4 weeks of treatment
|
Clinical scale for evaluating quality of upper limb movement (16 items, each assessed from 0 to 4 points).
Result reported in %.
Higher is better.
|
After 4 weeks of treatment
|
|
Quality of Upper Extremity Skills Test
Time Frame: After 4 weeks of treatment
|
Clinical scale evaluating the quality of upper extremity function (33 items, 4 domains).
Minimum score 0, maximum score 100.
Higher is better.
|
After 4 weeks of treatment
|
|
Active range of motion
Time Frame: After 4 weeks of treatment
|
Measured with goniometer in degrees.
|
After 4 weeks of treatment
|
|
Passive range of motion
Time Frame: After 4 weeks of treatment
|
Measured with goniometer in degrees.
|
After 4 weeks of treatment
|
|
Range of motion of target joint during a pointing-forward task
Time Frame: After 4 weeks of treatment
|
Measured in degrees.
A kinematic analysis will be performed during a pointing-forward task using an optoelectronic system.
|
After 4 weeks of treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 686
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.